After decriminalising cannabis in December 2020, Thailand became the first country in Asia to embrace the potential use of cannabis for medical and research purposes. This has garnered significant interest among both Thai and foreign stakeholders seeking to participate in the country’s upcoming medical cannabis industry.

Nonetheless, medical cannabis remains highly regulated and is subject to certain requirements. To keep stakeholders informed of such requirement, we have compiled a handbook highlighting what interested parties need to know in order to participate in Thailand’s upcoming medical cannabis industry. Points covered in this handbook include:

• The distinction between marijuana and hemp;
• Which applicants are eligible for licenses;
• Objectives for license applications; and
• Types of licenses.

You may access the handbook here.